Related Experiment Videos
Abbreviation or elimination of the crossmatch
Clinics in Laboratory Medicine
|March 1, 1982
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2001
Relationship between mammographic screening intervals and size and histology of ductal carcinoma in situ.
AJR. American journal of roentgenology·1999
Adenoid cystic carcinoma of the breast: value of histologic grading and proliferative activity.
The American journal of surgical pathology·1998
Nationwide survey of home transfusion practices.
Transfusion·1998
Metaplastic carcinoma of the breast: mammographic appearance with pathologic correlation.
AJR. American journal of roentgenology·1997
Applications of Deep Learning in Endocrine Neoplasms.
Clinics in laboratory medicine·2026
Scarless Surgery: Clinical Indications for Transoral Endocrine Surgery and Implications for Pathologists.
Clinics in laboratory medicine·2026
Light It Up! The Use of DOTATATE in Diagnosis and Treatment of Neuroendocrine Neoplasms.
Clinics in laboratory medicine·2026
All Together Now: Standardization of Nomenclature for Neuroendocrine Neoplasms across Multiple Organs.
Clinics in laboratory medicine·2026
Back to Biochemistry: Evaluation for and Prognostic Significance of SDH Mutations in Paragangliomas and Pheochromocytomas.
Clinics in laboratory medicine·2026
On the Chopping Block: Overview of DICER1 Mutations in Endocrine and Neuroendocrine Neoplasms.
Clinics in laboratory medicine·2026
Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.
British journal of haematology·2026
iPSC-derived neurospheres: A cellular platform for Tau and Alzheimer's disease immunotherapy.
Advances in immunology·2026
Expanding the therapeutic landscape of Still's disease: the emerging role of JAK inhibitors.
Expert opinion on pharmacotherapy·2026